Retatrutide is a newly developed therapy that acts as a strong GLP-1 receptor agonist. This revolutionary approach holds significant potential for regulating type 2 diabetes. By mimicking the actions of natural GLP-1, https://haimapsoy191990.elbloglibre.com/39317815/retatrudiate-a-novel-glp-1-receptor-agonist-for-diabetes-management